• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苄基和苯基胍及氨基胍腙衍生物的合成及体外抗菌构效关系研究。

Synthesis and In Vitro Antimicrobial SAR of Benzyl and Phenyl Guanidine and Aminoguanidine Hydrazone Derivatives.

机构信息

Medicinal Chemistry & Drug Discovery, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK.

Department of Pharmacy & Pharmacology, University of Bath, Claverton Down, Bath BA2 7AY, UK.

出版信息

Molecules. 2022 Dec 20;28(1):5. doi: 10.3390/molecules28010005.

DOI:10.3390/molecules28010005
PMID:36615201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9822361/
Abstract

A series of benzyl, phenyl guanidine, and aminoguandine hydrazone derivatives was designed and in vitro antibacterial activities against two different bacterial strains ( and ) were determined. Several compounds showed potent inhibitory activity against the bacterial strains evaluated, with minimal inhibitory concentration (MIC) values in the low µg/mL range. Of all guanidine derivatives, 3-[2-chloro-3-(trifluoromethyl)]-benzyloxy derivative showed the best potency with MICs of 0.5 µg/mL () and 1 µg/mL (), respectively. Several aminoguanidine hydrazone derivatives also showed good overall activity. Compounds , , and - displayed MICs of 4 µg/mL against both and . In the aminoguanidine hydrazone series, 3-(4-trifluoromethyl)-benzyloxy derivative showed the best potency against (MIC 1 µg/mL) but was far less active against (MIC 16 µg/mL). Compound and the -substituted derivative also showed promising results against two strains of methicillin-resistant (MRSA). These results provide new and potent structural leads for further antibiotic optimisation strategies.

摘要

设计了一系列苄基、苯胍和氨基胍腙衍生物,并测定了它们对两种不同细菌(和)的体外抗菌活性。一些化合物对评价的细菌菌株表现出很强的抑制活性,最低抑菌浓度(MIC)值在低μg/mL 范围内。在所有胍衍生物中,3-[2-氯-3-(三氟甲基)]苄氧基衍生物表现出最好的活性,MIC 分别为 0.5μg/mL()和 1μg/mL()。一些氨基胍腙衍生物也表现出良好的整体活性。化合物、和的 MIC 分别为 4μg/mL,对和均有抑制作用。在氨基胍腙系列中,3-(4-三氟甲基)苄氧基衍生物对(MIC 1μg/mL)表现出最好的活性,但对(MIC 16μg/mL)的活性要差得多。化合物和取代的衍生物对两种耐甲氧西林金黄色葡萄球菌(MRSA)也表现出有希望的结果。这些结果为进一步的抗生素优化策略提供了新的、有效的结构先导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/3d3b932580a2/molecules-28-00005-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/60f1143bf9fa/molecules-28-00005-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/1a5a7d0a4072/molecules-28-00005-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/d5007e1efadb/molecules-28-00005-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/33084ac34068/molecules-28-00005-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/13bf278e6479/molecules-28-00005-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/cf75522d71ae/molecules-28-00005-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/b298b31bb952/molecules-28-00005-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/7eec4a2ff56b/molecules-28-00005-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/2519f2b3474d/molecules-28-00005-sch007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/3d3b932580a2/molecules-28-00005-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/60f1143bf9fa/molecules-28-00005-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/1a5a7d0a4072/molecules-28-00005-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/d5007e1efadb/molecules-28-00005-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/33084ac34068/molecules-28-00005-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/13bf278e6479/molecules-28-00005-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/cf75522d71ae/molecules-28-00005-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/b298b31bb952/molecules-28-00005-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/7eec4a2ff56b/molecules-28-00005-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/2519f2b3474d/molecules-28-00005-sch007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f89/9822361/3d3b932580a2/molecules-28-00005-g003.jpg

相似文献

1
Synthesis and In Vitro Antimicrobial SAR of Benzyl and Phenyl Guanidine and Aminoguanidine Hydrazone Derivatives.苄基和苯基胍及氨基胍腙衍生物的合成及体外抗菌构效关系研究。
Molecules. 2022 Dec 20;28(1):5. doi: 10.3390/molecules28010005.
2
Synthesis and antimicrobial activity of some novel phenyl and benzimidazole substituted benzyl ethers.一些新型苯基和苯并咪唑取代苄基醚的合成及其抗菌活性
Bioorg Med Chem Lett. 2007 Apr 15;17(8):2233-6. doi: 10.1016/j.bmcl.2007.01.061. Epub 2007 Jan 25.
3
Antimicrobial evaluation of indole-containing hydrazone derivatives.含吲哚腙衍生物的抗菌评价。
Z Naturforsch C J Biosci. 2011 Jul-Aug;66(7-8):340-4. doi: 10.1515/znc-2011-7-804.
4
Investigation of antimicrobial activities of indole-3-aldehyde hydrazide/hydrazone derivatives.吲哚-3-醛酰肼/腙衍生物的抗菌活性研究
Chemotherapy. 2009;55(1):15-9. doi: 10.1159/000166999. Epub 2008 Oct 31.
5
Synthesis and Antimicrobial Studies of Coumarin-Substituted Pyrazole Derivatives as Potent Anti- Agents.香豆素取代吡唑衍生物的合成及抗菌研究作为有效的抗菌剂。
Molecules. 2020 Jun 15;25(12):2758. doi: 10.3390/molecules25122758.
6
Synthesis and in vitro antimicrobial activity of some novel substituted benzimidazole derivatives having potent activity against MRSA.一些对耐甲氧西林金黄色葡萄球菌(MRSA)具有强效活性的新型取代苯并咪唑衍生物的合成及体外抗菌活性
Eur J Med Chem. 2009 Mar;44(3):1024-33. doi: 10.1016/j.ejmech.2008.06.026. Epub 2008 Jul 4.
7
Synthesis, biofilm formation inhibitory, and inflammation inhibitory activities of new coumarin derivatives.新型香豆素衍生物的合成、生物膜形成抑制和炎症抑制活性。
Sci Rep. 2024 Apr 20;14(1):9106. doi: 10.1038/s41598-024-59072-w.
8
Synthesis and Evaluation of Hydrazonomethyl-Quinolin-8-ol and Pyrazol-3-yl-Quinolin-8-ol Derivatives for Antimicrobial and Antimalarial Potential.合成及评价肼甲基-8-喹啉醇和吡唑-3-基-8-喹啉醇衍生物的抗微生物和抗疟原虫潜力。
Med Chem. 2022;18(9):949-969. doi: 10.2174/1573406418666220303144929.
9
Quinoline Hydrazone Derivatives as New Antibacterials against Multidrug Resistant Strains.喹啉腙衍生物作为新型抗菌药物对抗多重耐药菌株。
Chem Biodivers. 2023 Sep;20(9):e202300839. doi: 10.1002/cbdv.202300839. Epub 2023 Aug 28.
10
Polyhexamethylene guanidine hydrochloride-based disinfectant: a novel tool to fight meticillin-resistant Staphylococcus aureus and nosocomial infections.基于盐酸聚六亚甲基胍的消毒剂:对抗耐甲氧西林金黄色葡萄球菌和医院感染的新工具。
J Med Microbiol. 2008 Dec;57(Pt 12):1523-1528. doi: 10.1099/jmm.0.2008/003350-0.

引用本文的文献

1
Synthesis, Antimicrobial Activities, and Model of Action of Novel Tetralone Derivatives Containing Aminoguanidinium Moiety.含氨基胍部分的新型四氢萘酮衍生物的合成、抗菌活性及作用模式
Int J Mol Sci. 2025 Jun 21;26(13):5980. doi: 10.3390/ijms26135980.
2
Metabolite Identification of Isopropoxy Benzene Guanidine in Rat Liver Microsomes by Using UHPLC-Q-TOF-MS/MS.采用 UHPLC-Q-TOF-MS/MS 技术鉴定大鼠肝微粒体中的异丙氧基苯胍
Int J Mol Sci. 2023 Apr 15;24(8):7313. doi: 10.3390/ijms24087313.

本文引用的文献

1
Combination with a FtsZ inhibitor potentiates the in vivo efficacy of oxacillin against methicillin-resistant .与FtsZ抑制剂联合使用可增强苯唑西林对耐甲氧西林菌的体内疗效。
Med Chem Res. 2022 Oct;31(10):1705-1715. doi: 10.1007/s00044-022-02960-5. Epub 2022 Sep 5.
2
Antimicrobial drugs bearing guanidine moieties: A review.胍基抗菌药物:综述。
Eur J Med Chem. 2021 Apr 15;216:113293. doi: 10.1016/j.ejmech.2021.113293. Epub 2021 Feb 13.
3
Structure-Guided Design of a Fluorescent Probe for the Visualization of FtsZ in Clinically Important Gram-Positive and Gram-Negative Bacterial Pathogens.
基于结构的荧光探针设计用于可视化临床重要的革兰氏阳性和革兰氏阴性细菌病原体中的 FtsZ。
Sci Rep. 2019 Dec 27;9(1):20092. doi: 10.1038/s41598-019-56557-x.
4
Structural Flexibility of an Inhibitor Overcomes Drug Resistance Mutations in Staphylococcus aureus FtsZ.抑制剂的结构灵活性克服了金黄色葡萄球菌FtsZ中的耐药突变。
ACS Chem Biol. 2017 Jul 21;12(7):1947-1955. doi: 10.1021/acschembio.7b00323. Epub 2017 Jun 16.
5
TXA709, an FtsZ-Targeting Benzamide Prodrug with Improved Pharmacokinetics and Enhanced In Vivo Efficacy against Methicillin-Resistant Staphylococcus aureus.TXA709,一种靶向FtsZ的苯甲酰胺前药,具有改善的药代动力学和增强的体内抗耐甲氧西林金黄色葡萄球菌疗效。
Antimicrob Agents Chemother. 2015 Aug;59(8):4845-55. doi: 10.1128/AAC.00708-15. Epub 2015 Jun 1.
6
TXA497 as a topical antibacterial agent: comparative antistaphylococcal, skin deposition, and skin permeation studies with mupirocin.TXA497 作为一种局部抗菌剂:与莫匹罗星相比的抗葡萄球菌、皮肤沉积和皮肤渗透研究。
Int J Pharm. 2014 Dec 10;476(1-2):199-204. doi: 10.1016/j.ijpharm.2014.09.033. Epub 2014 Sep 26.
7
Bacterial cell division as a target for new antibiotics.细菌细胞分裂作为新抗生素的作用靶点。
Curr Opin Microbiol. 2013 Oct;16(5):522-30. doi: 10.1016/j.mib.2013.07.006. Epub 2013 Aug 8.
8
Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines.喹喔啉、喹唑啉和 1,5-萘啶的抗菌活性。
Bioorg Med Chem Lett. 2013 Sep 1;23(17):4968-74. doi: 10.1016/j.bmcl.2013.06.048. Epub 2013 Jun 26.
9
Novel berberine triazoles: synthesis, antimicrobial evaluation and competitive interactions with metal ions to human serum albumin.新型小檗碱三唑类化合物的合成、抗菌评价及与人血清白蛋白的竞争相互作用与金属离子。
Bioorg Med Chem Lett. 2013 Feb 15;23(4):1008-12. doi: 10.1016/j.bmcl.2012.12.036. Epub 2012 Dec 20.
10
3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agents.3-苯基取代的 6,7-二甲氧基异喹啉衍生物作为 FtsZ 靶向抗菌剂。
Bioorg Med Chem. 2012 Dec 15;20(24):7012-29. doi: 10.1016/j.bmc.2012.10.009. Epub 2012 Oct 17.